Novavax NVAX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $228.36M-5.1% | $240.63M-10.2% | $268.02M+5.6% | $253.74M-3.6% | $263.34M-50.3% | ||
| $561.97M+13.7% | $494.45M-0.1% | $494.87M+38.0% | $358.56M-23.4% | $468.14M+19.2% | ||
| $0-100% | $10.88M+0.6% | $10.82M+0.6% | $10.75M+0.6% | $10.68M+0.5% | ||
| $11.46M-0.8% | $11.55M-14.6% | $13.51M+31.9% | $10.24M-0.2% | $10.26M+17.3% | ||
| $25.71M-4.1% | $26.82M-41.1% | $45.53M-23.9% | $59.82M-15.9% | $71.1M-9.0% | ||
| $0-100% | $87.51M-18.7% | $107.66M— | —— | —— | ||
| $850.82M-13.0% | $978.28M+0.4% | $974.59M+6.0% | $919.51M+5.9% | $868.03M-23.1% | ||
| $42.15M-5.9% | $44.8M-8.8% | $49.12M-62.1% | $129.64M-2.9% | $133.54M-3.5% | ||
| $112.89M-0.5% | $113.46M+0.3% | $113.08M+0.1% | $112.96M+0.8% | $112.03M+4.2% | ||
| $15.95M-6.6% | $17.08M-11.2% | $19.23M-10.1% | $21.39M-2.3% | $21.9M-8.7% | ||
| $1.04B-11.3% | $1.18B-0.3% | $1.18B-11.7% | $1.34B+3.4% | $1.29B-17.1% | ||
| $16.1M-34.5% | $24.58M+61.4% | $15.23M-69.9% | $50.6M+48.1% | $34.16M-17.8% | ||
| $132.45M-3.9% | $137.78M-0.4% | $138.33M+4.4% | $132.53M-6.7% | $142.03M-35.3% | ||
| $88.77M-36.6% | $140.05M+34.3% | $104.25M-8.4% | $113.76M+5.0% | $108.33M-84.0% | ||
| $2.11M-15.8% | $2.51M-50.2% | $5.04M-9.3% | $5.55M+1.4% | $5.48M-21.8% | ||
| —— | $9.88M— | —— | —— | —— | ||
| $2.11M-15.8% | $2.51M-50.2% | $5.04M-9.3% | $5.55M+1.4% | $5.48M-21.8% | ||
| $0-100% | $47.87M-6.9% | $51.44M— | —— | —— | ||
| $359.27M+0.1% | $358.94M-9.6% | $397.11M-0.5% | $399.26M-2.5% | $409.56M-8.3% | ||
| $342.46M-25.5% | $459.95M+7.0% | $429.87M+10.5% | $389.14M-7.8% | $422.17M-63.4% | ||
| $291.04M+19.2% | $244.21M— | —— | —— | —— | ||
| $1.91M-8.8% | $2.09M-7.8% | $2.27M-95.7% | $52.37M-1.3% | $53.06M-1.2% | ||
| $193.24M-19.2% | $239.07M-9.3% | $263.48M-8.4% | $287.59M-8.3% | $313.73M-12.8% | ||
| $1.19B-8.9% | $1.3B-2.4% | $1.34B+2.9% | $1.3B-5.1% | $1.37B-37.3% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $1.68M+1.7% | $1.65M+0.1% | $1.65M+0.2% | $1.65M+0.2% | $1.64M+1.4% | ||
| $4.55B+0.2% | $4.54B+0.2% | $4.53B+0.2% | $4.52B+0.2% | $4.51B+0.3% | ||
| -$4.58B-0.2% | -$4.57B+0.4% | -$4.59B-4.6% | -$4.38B+2.4% | -$4.49B+10.4% | ||
| -$5.07M-352% | $2.01M+215% | -$1.75M-281% | -$458K-128% | $1.61M+107% | ||
| $112.32M+9.0% | $103.02M+0.3% | $102.66M+0.2% | $102.46M+0.5% | $101.94M+6.3% | ||
| -$144.76M-13.3% | -$127.75M+18.5% | -$156.67M-516% | $37.63M+150% | -$75.64M+87.9% | ||
| $1.04B-11.3% | $1.18B-0.3% | $1.18B-11.7% | $1.34B+3.4% | $1.29B-17.1% | ||
| —— | —— | —— | —— | —— | ||
| $561.97M+13.7% | $494.45M-0.1% | $494.87M+38.0% | $358.56M-23.4% | $468.14M+19.2% | ||
| $15.95M-6.6% | $17.08M-11.2% | $19.23M-10.1% | $21.39M-2.3% | $21.9M-8.7% | ||
| $21.36M-6.7% | $22.9M-4.1% | $23.87M-84.4% | $153.04M-2.8% | $157.5M-2.5% | ||
| $15.95M-6.6% | $17.08M-11.2% | $19.23M-10.1% | $21.39M-2.3% | $21.9M-8.7% | ||
| $15.95M-6.6% | $17.08M-11.2% | $19.23M-10.1% | $21.39M-2.3% | $21.9M-8.7% | ||
| $359.27M+0.1% | $358.94M-9.6% | $397.11M-0.5% | $399.26M-2.5% | $409.56M-8.3% | ||
| $103.03M-3.9% | $107.17M-7.3% | $115.59M+33.3% | $86.7M-34.4% | $132.17M-37.4% | ||
| $103.03M-3.9% | $107.17M-7.3% | $115.59M+33.3% | $86.7M-34.4% | $132.17M-37.4% | ||
| $132.45M-3.9% | $137.78M-0.4% | $138.33M+4.4% | $132.53M-6.7% | $142.03M-35.3% | ||
| $359.27M+0.1% | $358.94M-9.6% | $397.11M-0.5% | $399.26M-2.5% | $409.56M-8.3% | ||
| $359.27M+0.1% | $358.94M-9.6% | $397.11M-0.5% | $399.26M-2.5% | $409.56M-8.3% | ||
| $295.06M+5.2% | $280.56M+3,741% | $7.31M-87.4% | $57.92M-1.0% | $58.53M-41.9% | ||
| $1.68M+1.7% | $1.65M+0.1% | $1.65M+0.2% | $1.65M+0.2% | $1.64M+1.4% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $23.31M-78.1% | $106.45M+211% | $34.17M-84.9% | $226.4M+409% | $44.51M-58.9% | ||
| $2.11M-15.8% | $2.51M-50.2% | $5.04M-9.3% | $5.55M+1.4% | $5.48M-21.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Novavax's total assets?
- Novavax (NVAX) holds $1.0B in total assets, down 19.3% year over year.
- How much debt does Novavax have?
- Novavax carries $295.1M in total debt against -$144.8M of shareholders' equity, a debt-to-equity ratio of 1.54.
- How much cash does Novavax have?
- Novavax holds $228.4M in cash and equivalents.
- Can Novavax cover its short-term obligations?
- Its current ratio is 2.48 — current assets exceed current liabilities.
- Where does Novavax's balance sheet data come from?
- Every line is extracted from Novavax's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
